The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of enzalutamide with oral decitabine/cedazuridine in metastatic castration-resistant prostate cancer (CRPC).
 
Arya Mariam Roy
No Relationships to Disclose
 
Dharmesh Gopalakrishnan
No Relationships to Disclose
 
Karan Jatwani
No Relationships to Disclose
 
Kelly Green
No Relationships to Disclose
 
Bailey Farmer
No Relationships to Disclose
 
Neha Jaiswal
No Relationships to Disclose
 
Kristopher Attwood
No Relationships to Disclose
 
Ellis Glenn Levine
Patents, Royalties, Other Intellectual Property - UpToDate
 
Himisha Beltran
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Blue Earth Diagnostics; Curie Therapeutics; Daicchi Sankyo; Foundation Medicine; Janssen Oncology; Loxo/Lilly; Merck; Novartis; Pfizer; Sanofi
Research Funding - Abbvie/Stemcentrx (Inst); Bristol Myers Squibb Foundation (Inst); Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
David Goodrich
No Relationships to Disclose
 
Gurkamal S. Chatta
Consulting or Advisory Role - Cardinal Health
Research Funding - Abbvie (Inst); Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Cardinal Health